A randomized, open-label Phase 2 clinical trial of BMS-986012 in combination with Carboplatin, Etoposide, and Nivolumab as first-line therapy in extensive stage small cell lung cancer [CA001-050]

  • Markman, Ben (Primary Chief Investigator (PCI))
  • Lai, Li Hoon (Project Manager)

Project: Research

Project Details

Effective start/end date10/06/2131/12/25


  • Small cell lung cancer
  • Oncology
  • Cancer treatment
  • Clinical trial